J&J eyes contact lens solution market
This article was originally published in The Gray Sheet
The aftermath of an outbreak of eye infections linked to contact lens care solutions made by Bausch & Lomb provides a "significant" opportunity for Johnson & Johnson/Vistakon to move into the solution arena, Dan Casey, group chairman of the eye products unit says Sept. 6. The recent Fusarium keratitis infections, which resulted in a worldwide recall of B&L's ReNu with MoistureLoc solution, open the door to "bring real innovation to the category," according to Casey. Vistakon is looking at acquisitions and licensing that would allow the firm to participate in the solutions market (1"The Gray Sheet" May 22, 2006, p. 17). J&J's pending acquisition of Pfizer's consumer products business will complement J&J's Acuvue contact lens line by adding Pfizer's Visine eye drops...
You may also be interested in...
With evidence pointing to the basic formulation of Bausch & Lomb's ReNu with MoistureLoc contact lens solution as a contributing factor in an outbreak of serious eye infections, the company bit the bullet May 15 and issued a permanent, worldwide recall of the lucrative product
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.